CLBT Quote, Financials, Valuation and Earnings

Formula Systems (1985) has a net margin of 17.67% compared to Cellebrite DI's net margin of 2.9%. Cellebrite DI's return on equity of -235.18% beat Formula Systems (1985)'s return on equity of 5.95%.

Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 40.38%. On the other hand Formula Systems (1985) has an analysts' consensus of -- which suggests that it could fall by --. Given that Cellebrite DI has higher upside potential than Formula Systems (1985), analysts believe Cellebrite DI is more attractive than Formula Systems (1985).

Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Formula Systems (1985) has a beta of 1.021, suggesting its more volatile than the S&P 500 by 2.146%.

Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Formula Systems (1985) offers a yield of 1.35% to investors and pays a quarterly dividend of $0.62 per share. Cellebrite DI pays -- of its earnings as a dividend. Formula Systems (1985) pays out -- of its earnings as a dividend.

Cellebrite DI quarterly revenues are $109M, which are smaller than Formula Systems (1985) quarterly revenues of $691.5M. Cellebrite DI's net income of $19.3M is lower than Formula Systems (1985)'s net income of $20.1M. Notably, Cellebrite DI's price-to-earnings ratio is -- while Formula Systems (1985)'s PE ratio is 17.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.25x versus 0.52x for Formula Systems (1985). Usually stocks with elevated PS ratios are considered overvalued.

Nova has a net margin of 17.67% compared to Cellebrite DI's net margin of 25.92%. Cellebrite DI's return on equity of -235.18% beat Nova's return on equity of 21.77%.

Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 40.38%. On the other hand Nova has an analysts' consensus of $279.59 which suggests that it could grow by 42.18%. Given that Nova has higher upside potential than Cellebrite DI, analysts believe Nova is more attractive than Cellebrite DI.

Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nova has a beta of 1.627, suggesting its more volatile than the S&P 500 by 62.737%.

Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nova offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. Nova pays out -- of its earnings as a dividend.

Cellebrite DI quarterly revenues are $109M, which are smaller than Nova quarterly revenues of $194.8M. Cellebrite DI's net income of $19.3M is lower than Nova's net income of $50.5M. Notably, Cellebrite DI's price-to-earnings ratio is -- while Nova's PE ratio is 34.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.25x versus 9.38x for Nova. Usually stocks with elevated PS ratios are considered overvalued.

SatixFy Communications has a net margin of 17.67% compared to Cellebrite DI's net margin of -539.62%. Cellebrite DI's return on equity of -235.18% beat SatixFy Communications's return on equity of --.

Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 40.38%. On the other hand SatixFy Communications has an analysts' consensus of $2.50 which suggests that it could grow by 25%. Given that Cellebrite DI has higher upside potential than SatixFy Communications, analysts believe Cellebrite DI is more attractive than SatixFy Communications.

Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SatixFy Communications has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SatixFy Communications offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. SatixFy Communications pays out -- of its earnings as a dividend.

Cellebrite DI quarterly revenues are $109M, which are larger than SatixFy Communications quarterly revenues of $2.5M. Cellebrite DI's net income of $19.3M is higher than SatixFy Communications's net income of -$13.3M. Notably, Cellebrite DI's price-to-earnings ratio is -- while SatixFy Communications's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.25x versus 8.11x for SatixFy Communications. Usually stocks with elevated PS ratios are considered overvalued.

Silynxcom has a net margin of 17.67% compared to Cellebrite DI's net margin of --. Cellebrite DI's return on equity of -235.18% beat Silynxcom's return on equity of --.

Cellebrite DI has a consensus price target of $27.57, signalling upside risk potential of 40.38%. On the other hand Silynxcom has an analysts' consensus of -- which suggests that it could grow by 346.93%. Given that Silynxcom has higher upside potential than Cellebrite DI, analysts believe Silynxcom is more attractive than Cellebrite DI.

Cellebrite DI has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Silynxcom has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Cellebrite DI has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Silynxcom offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cellebrite DI pays -- of its earnings as a dividend. Silynxcom pays out -- of its earnings as a dividend.

Cellebrite DI quarterly revenues are $109M, which are larger than Silynxcom quarterly revenues of --. Cellebrite DI's net income of $19.3M is higher than Silynxcom's net income of --. Notably, Cellebrite DI's price-to-earnings ratio is -- while Silynxcom's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cellebrite DI is 10.25x versus -- for Silynxcom. Usually stocks with elevated PS ratios are considered overvalued.